Literature DB >> 271994

Interactions of C-reactive protein and complement with liposomes.

R L Richards, H Gewurz, A P Osmand, C R Alving.   

Abstract

Interactions between C-reactive protein (CRP) and liposomal model membranes containing phosphatidylcholine were investigated. These interactions, in the presence of human serum, resulted in consumption of each of the components of the classical complement pathway (C1-C9) and also resulted in complement-dependent damage and release of trapped glucose from certain types of liposomes. CRP-initiated lysis of liposomes was strongly dependent upon membrane lipid composition. Optimal activity occurred with positively charged liposomes containing galactosylceramide (galactocerebroside); positively charged liposomes lacking galactocerebroside released much less glucose, while negatively charged liposomes, either with or without galactocerebroside, did not release glucose at all. Glucose release was inhibited by free phosphocholine. Lesser, but significant, "background" glucose release independent of the presence of CRP also was observed with positively charged liposomes containing galactocerebroside, and this was associated with marked preferential consumption of the later-acting complement components (C3-C9). C2-deficient human serum failed to support CRP-dependent glucose release, but glucose release was observed upon reconstitution of the serum with C2. Guinea pig complement also did not support CRP-mediated glucose release, but upon addition of human C1q substantial glucose release was observed. We conclude that (i) CRP can sensitize appropriate liposomes for complement-dependent damage via the primary complement pathway starting at the level of C1q; (ii) of those studied, liposomes that are most susceptible to membrane damage contain phosphatidylcholine, have a positive charge, and contain a ceramide glycolipid; and (iii) such liposomes also are sensitive, although to a much lesser degree, to complement-dependent lysis initiated in the absence of CRP and involving consumption of terminal in excess of early acting complement components.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 271994      PMCID: PMC431855          DOI: 10.1073/pnas.74.12.5672

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.

Authors:  J E Volanakis; M H Kaplan
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

2.  Preparation of liposomes and a spectrophotometric assay for release of trapped glucose marker.

Authors:  S C Kinsky
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.

Authors:  J E Volanakis; M H Kaplan
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

4.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  Radioimmunoassay of human C-reactive protein and levels in normal sera.

Authors:  D R Claus; A P Osmand; H Gewurz
Journal:  J Lab Clin Med       Date:  1976-01

6.  Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers.

Authors:  R A Demel; W S Geurts van Kessel; R F Zwaal; B Roelofsen; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1975-09-16

7.  Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.

Authors:  C R Alving; R L Richards; A A Guirguis
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

9.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations.

Authors:  J Siegel; A P Osmand; M F Wilson; H Gewurz
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

3.  Calcium-dependent binding of rabbit C-reactive protein to supported lipid monolayers containing exposed phosphorylcholine group.

Authors:  S F Sui; Y T Sun; L Z Mi
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

4.  Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.

Authors:  N Okada; T Yasuda; T Tsumita; H Okada
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

5.  Glycine, serine and threonine metabolism confounds efficacy of complement-mediated killing.

Authors:  Zhi-Xue Cheng; Chang Guo; Zhuang-Gui Chen; Tian-Ci Yang; Jian-Ying Zhang; Jie Wang; Jia-Xin Zhu; Dan Li; Tian-Tuo Zhang; Hui Li; Bo Peng; Xuan-Xian Peng
Journal:  Nat Commun       Date:  2019-07-25       Impact factor: 14.919

Review 6.  Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.

Authors:  Ninh M La-Beck; Md Rakibul Islam; Maciej M Markiewski
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 7.  Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities.

Authors:  Lawrence A Potempa; Wei Qiao Qiu; Ashley Stefanski; Ibraheem M Rajab
Journal:  Front Cardiovasc Med       Date:  2022-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.